¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"protein modification"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
allotropic modification
µ¿¼Òüº¯Çü
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯Çü, º¯È, º¯°æ, ¼ö½Ä, ¼öÁ¤
phenotypic modification
Ç¥ÇöÇüº¯È
antifreeze protein
Ç×µ¿°á´Ü¹éÁú
antiviral protein
Ç×¹ÙÀÌ·¯½º´Ü¹éÁú
adherence protein
ºÎÂø´Ü¹éÁú
androgen binding protein
¾Èµå·Î°Õ°áÇմܹéÁú
Bence Jones protein
º¥½º-Á¸½º´Ü¹éÁú
coat protein
¿ÜÇǴܹéÁú
competitive protein binding radioassay
°æÇմܹéÁú°áÇÕ¹æ»çÃøÁ¤(¹ý)
conjugated protein
Á¢ÇմܹéÁú, °áÇմܹéÁú
contractile protein
¼öÃà´Ü¹éÁú
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
9
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
modification
º¯È, ¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
protein binding
´Ü¹é°áÇÕ
protein-losing enteropathy
´Ü¹é¼Ò½ÇâÀÚº´Áõ
protein
´Ü¹é, ´Ü¹éÁú
adherence protein
ºÎÂø´Ü¹é
reserve protein
ÀúÀå´Ü¹é
split-timed urine protein
½Ã°£´ëº°¿ä´Ü¹éÁ¤·®
structural protein
±¸Á¶´Ü¹é, ±¸Á¶´Ü¹éÁú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification
º¯È, ¼ö½Ä
phenotypic modification
Ç¥ÇöÇüº¯È
adherence protein
ºÎÂø´Ü¹é
antifreeze protein
Ç×µ¿°á´Ü¹éÁú
protein binding
´Ü¹é°áÇÕ
carrier protein
¿î¹Ý´Ü¹é, ¿î¹Ý´Ü¹éÁú
catabolite activating protein
ÀÌȻ깰Ȱ¼ºÈ´Ü¹é
coat protein
¿ÜÇǴܹé
competitive protein binding radioassay
°æÇմܹé°áÇÕ¹æ»çÃøÁ¤(¹ý)
conjugated protein
º¹Çմܹé, Á¢ÇմܹéÁú
contractile protein
¼öÃà´Ü¹éÁú
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
AA protein
¾Æ¹Ð·ÎÀ̵åA´Ü¹é(¡Ó±ÛÜ)
ABP=> androgen-binding protein
¾Èµå·ÎÁ¨°áÇմܹé
Bence Jones protein
º¥½º-Á¸½º´Ü¹é.
Bence-Jones protein
º¥½º-Á¸½º ´Ü¹éÁú
C protein
C´Ü¹éÁú
C-Fos protein
¾¾-Æ÷½º´Ü¹é(Ó±ÛÜ)
C-reative protein =CRP
C¹ÝÀÀ¼º ´Ü¹é(Áú).
C-reative protein =CRP
[¸é¿ª] [ÀÓº´]C¹ÝÀÀ¼º ´Ü¹éÁú.
DNA-binding protein
DNA °áÇմܹéÁú
G protein
G ´Ü¹é(Ó±ÛÜ)
G-myeloma protein
¸é¿ª±Û·ÎºÒ¸° G-°ñ¼öÁ¾´Ü¹éÁú
Heat shock protein
¿¼ï´Ü¹éÁú
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
allotropic modification
µ¿¼Òüº¯Çü(ÔÒáÈô÷ܨû¡).
antigen modification
Ç׿øº¯Çü.
behavior modification technique
Çൿ(ÇàÅÂ)¼öÁ¤±â¹ý
behavioral modification
Çൿ¼öÁ¤
host-controlled modification
¼÷ÁÖÁ¶Àý¼ö½Ä
modification of karyotype
ÇÙÇüº¯ÀÌ
modification, behavioral
phenotypic modification
Ç¥ÇöÇü ¼ö½Ä, Ç¥ÇöÇü º¯È
actin-binding protein
¾×ƾ °áÇմܹé(¡Ì¿ùêÓ±ÛÜ)
activated protein C inhibitor
Ȱ¼ºÈ´Ü¹éÁú C ¾ïÁ¦Á¦
activated protein C resistance
Ȱ¼ºÈC´Ü¹é³»¼º
acute phase protein
±Þ¼ºº´±â´Ü¹éÁú
acute phase reactive protein
±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
al protein
AL ´Ü¹é(¡Ó±ÛÜ)
amyloid precurssor protein
¾Æ¹Ð·ÎÀ̵å Àü±¸ ´Ü¹éÁú
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½